Company intelligence / Profile preview

Prometheon Pharma

Gainesville, Florida, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~3
Development stage: Preclinical

Overview

Prometheon Pharma has developed a proprietary transdermal patch technology aimed at delivering large-molecule therapeutics such as insulin and growth hormones without needles. The company’s Topicon™ platform enables extended-wear patches for once-weekly dosing. No published clinical results are available; the company appears to be in preclinical or prototype stages.

Therapeutic areas: EndocrinologyImmunology
Modalities: Transdermal delivery of large molecules (e.g., recombinant human proteins, peptides)Focus on drugs like insulin, growth hormone, and vaccines
Industry: Biotech

Drug pipeline

4 assets

TruePatch insulin

Pre-clinical

Indications: Type 2 diabetes, Prediabetes

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Prometheon Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prometheon Pharma.

Explore the full profile